Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Marker Chromosomes Are a New Cytogenetic Adverse Risk Factor in AML after Allo-HCT

Kyoko Fuse, MD, Tomoyuki Tanaka, MD PhD, Shun Uemura, MD, Tatsuya Suwabe, MD, Takayuki Katagiri, MD, Takashi Ushiki, MD PhD, Yasuhiko Shibasaki, MD, Naoko Sato, MD PhD, Toshio Yano, MD PhD, Takashi Kuroha, MD PhD, Shigeo Hashimoto, MD PhD, Tastuo Furukawa, MD PhD, Miwako Narita, MD PhD, Hirohito Sone, MD PhD, Masayoshi Masuko, MD PhD

Blood (2018) 132 (Supplement 1): 5260.

https://doi.org/10.1182/blood-2018-99-113251

Published: 2018

Journal Articles

Impact of Cytogenetics on Outcome of AML after Allogeneic Hematopoietic Stem Cell Transplantation

Tatiana L Gindina, MDPhD, Nikolay N Mamaev, Professor, Boris V Afanasyev, Professor, Sergey N Bondarenko, PhD, Alexander Alyanskiy, MDPhD, Olga Slesarchuk, MDPhD, Ivan S Moiseev, MDPhD, Svetlana V Razumova, MD, Lyudmila Zubarovskaya, Professor

Blood (2015) 126 (23): 4951.

https://doi.org/10.1182/blood.V126.23.4951.4951

Published: 2015

Journal Articles

Monosomal Karyotype Predicts Adverse Prognosis In Patients With Chronic Myelomonocytic Leukemia

Aysha K Alsahlawi, Hassan Alkhateeb, MD, Mrinal M. Patnaik, MBBS, Kebede Begna, MD, Michelle Elliott, MD, William Hogan, MD, Rhett P Ketterling, Mark R. Litzow, MD, Aref Al-Kali, MD

Blood (2013) 122 (21): 1334.

https://doi.org/10.1182/blood.V122.21.1334.1334

Published: 2013

Journal Articles

Decitabine (DAC) Vs. Best Supportive Care in Elderly Patients with Intermediate- and High-Risk MDS with or without Monosomal Karyotypes: Results of the EORTC-LG/German MDS-SG Randomized Phase III Trial 06011.

Blood (2012) 120 (21): 2804.

https://doi.org/10.1182/blood.V120.21.2804.2804

Published: 2012

Journal Articles

Unveiling the complexity of CK+ AML

Bruno C. Medeiros

Blood (2012) 119 (9): 1958–1959.

https://doi.org/10.1182/blood-2012-01-401505

Published: 2012

Journal Articles

Outcome of Older AML Patients with Adverse Cytogenetics, Including Single or Multiple Monosomies, Treated with the DNA Hypomethylating Agent Decitabine

Michael Lübbert, Claudia Schmoor, Anne Hagemeijer, Björn Hackanson, Rainer Claus, Björn Rüter, Mathias Schmid, Ulrich Germing, MD, Andrea Kuendgen, Volker Rethwisch, Arnold Ganser, MD, Uwe Platzbecker, MD, Oliver Galm, Wolfram Brugger, Gerhard Heil, Pierre W. Wijermans, Konstanze Döhner, Hartmut Döhner

Blood (2011) 118 (21): 2609.

https://doi.org/10.1182/blood.V118.21.2609.2609

Published: 2011

Journal Articles

IL-17 Positive Lymphocytes Predominantly Home At the Mucous Than in the Skin in cGvHD Patients

Aleksandra Klimczak, PhD, Krzysztof Suchnicki, PhD, Andrzej Lange, MD, DSci

Blood (2011) 118 (21): 3053.

https://doi.org/10.1182/blood.V118.21.3053.3053

Published: 2011

Journal Articles

TP53 Alterations in Acute Myeloid Leukemia with Complex Karyotype Correlate with Specific Copy Number Alterations, Monosomal Karyotype, and Dismal Outcome,

Blood (2011) 118 (21): 3558.

https://doi.org/10.1182/blood.V118.21.3558.3558

Published: 2011

Journal Articles

The Influence of Monosomal Karyotype On Survival in Patients with Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Survey On Behalf of the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)

Angelique V.M. Brands-Nijenhuis, MD, Myriam Labopin, MD, MS, Harry C. Schouten, MD, PhD, Liisa Volin, Gérard Socié, Jan J Cornelissen, MD PhD, Michel Attal, MD, Reza Tabrizi, MD, Jordi Esteve, MD, PhD, Mohamad Mohty

Blood (2011) 118 (21): 158.

https://doi.org/10.1182/blood.V118.21.158.158

Published: 2011

Journal Articles

Complex Karyotype Predicts Outcome Better Than Monosomal Karyotype In Patients with MDS/Secondary Acute Leukemia Treated with Allogeneic Hematopoietic Stem Cell Transplantation (HSCT): a Retrospective Survey on Behalf of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)

Angelique .M. Brands-Nijenhuis, V, MD, Michel van Gelder, Theo M. de Witte, MD, Johannes Schetelig, Anja van Biezen, Nicolaus Kroeger

Blood (2010) 116 (21): 578.

https://doi.org/10.1182/blood.V116.21.578.578

Published: 2010

Journal Articles

Monosomal Karyotype (MK) In Older Patients with Acute Myeloid Leukemia (AML) on Eastern Cooperative Oncology Group (ECOG) Therapeutic Trials: Poor Prognostic Impact of MK, but Not of Monosomy 7

Stephen A Strickland, MD, MSCI, Zhuoxin Sun, PhD, Rhett P Ketterling, MD, Athena M Cherry, PhD, Larry D Cripe, MD, Gordon Dewald, PhD, Rodney R Higgins, PhD, MS, Hillard M Lazarus, MD, Mark R Litzow, MD, Selina M Luger, MD, Elisabeth Paietta, PhD, Jacob M Rowe, MD, Hajime Uno, PhD, Gail H Vance, MD, Martin S Tallman, MD

Blood (2010) 116 (21): 579.

https://doi.org/10.1182/blood.V116.21.579.579

Published: 2010

Journal Articles

Microvesicle Information Transfer from Lung to Marrow Cells.

Jason Aliotta, MD, Sam Faradyan, MD, Mark Dooner, Gerri Dooner, Peter J. Quesenberry, MD

Blood (2007) 110 (11): 437.

https://doi.org/10.1182/blood.V110.11.437.437

Published: 2007

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) Is Followed by Epithelial Chimerism of the Oral Mucosal.

Alexandros Spyridonidis, M.D., Yannis Metaxas, M.D., Robert Zeiser, M.D., Miguel Waterhouse, Ph.D., Phillip Faber, M.D., Jurgen Finke, M.D.

Blood (2004) 104 (11): 2699.

https://doi.org/10.1182/blood.V104.11.2699.2699

Published: 2004

Journal Articles

Incorporation of Bone Marrow Derived Cells in Colonic Adenoma.

Christopher R. Cogle, MD, Neil D. Theise, MD, Marda L. Jorgensen, Doug Smith, Swan L. Thung, PhD, Chen Liu, MD, PhD, John R. Wingard, MD, Edward W. Scott, PhD

Blood (2004) 104 (11): 674.

https://doi.org/10.1182/blood.V104.11.674.674

Published: 2004

NARROW

Marker Chromosomes Are a New Cytogenetic Adverse Risk Factor in AML after Allo-HCT

Impact of Cytogenetics on Outcome of AML after Allogeneic Hematopoietic Stem Cell Transplantation

Monosomal Karyotype Predicts Adverse Prognosis In Patients With Chronic Myelomonocytic Leukemia

Decitabine (DAC) Vs. Best Supportive Care in Elderly Patients with Intermediate- and High-Risk MDS with or without Monosomal Karyotypes: Results of the EORTC-LG/German MDS-SG Randomized Phase III Trial 06011.

Unveiling the complexity of CK+ AML

Outcome of Older AML Patients with Adverse Cytogenetics, Including Single or Multiple Monosomies, Treated with the DNA Hypomethylating Agent Decitabine

IL-17 Positive Lymphocytes Predominantly Home At the Mucous Than in the Skin in cGvHD Patients

TP53 Alterations in Acute Myeloid Leukemia with Complex Karyotype Correlate with Specific Copy Number Alterations, Monosomal Karyotype, and Dismal Outcome,

The Influence of Monosomal Karyotype On Survival in Patients with Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Survey On Behalf of the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)

Monosomal Karyotype (MK) In Older Patients with Acute Myeloid Leukemia (AML) on Eastern Cooperative Oncology Group (ECOG) Therapeutic Trials: Poor Prognostic Impact of MK, but Not of Monosomy 7

Microvesicle Information Transfer from Lung to Marrow Cells.

Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) Is Followed by Epithelial Chimerism of the Oral Mucosal.

Incorporation of Bone Marrow Derived Cells in Colonic Adenoma.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only